Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract …
Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing. News and analysis on clinical trial services and contract research and development. Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist. Wegovy manufacturer Ascendis Pharma has been tasked with supporting the ...
Outsourcing-Pharma RSS
Seaport Therapeutics closes $225 million Series B to develop neuropsychiatric drugs. Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts at TechBio UK 2024, an event run by the BioIndustry Association (BIA). Investors and big pharma no longer avoiding techbio companies.
Interview: Adragos Pharma and the evolving world of outsourcing
Oct 4, 2024 · Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How has the role of contract development and manufacturing organizations (CDMOs) evolved over the ...
GSK's £200 million investment in the UK and $1.1 billion acquisition
Jan 16, 2024 · GSK to pump £200 million into UK to boost medicine production and buys Aiolos Bio for $1.1 billion. Pharma giant, GSK, plans to invest £200 million ($253 million) into the UK over the next two years and has acquired Aiolos Bio for $1.1 billion (£870 million). The company formerly known as Glaxosmithkline will put the money towards its sites ...
Insilico’s lead drug meets safety and efficacy goals in IPF trial
Sep 19, 2024 · Insilico Medicine, a biotech company with offices in both China and the US, announced this week that its lead candidate drug had met its primary endpoint of safety and its secondary efficacy endpoints. INS018_055 (also known as ISM001-055) is a small molecule drug candidate targeting TRAF2- and NCK-interacting kinase (TNIK).
Ukraine war dramatically impacting global clinical development
Mar 24, 2022 · Clinical tech services company Phesi has released a report showing the extent of the impact of the war in Ukraine on clinical development. The report takes a look at “pivotal” trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities. According to the findings, as of March 16, 2022 ...
FDA clearance to start clinical trials with new obesity drug
Oct 10, 2024 · Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug. The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a first-in-class treatment for obesity. Antag Therapeutics has announced that the FDA has accepted the investigational new drug (IND) application ...
Lonza steps up oligonucleotides production
Feb 26, 2003 · The Lonza facility at Visp, Switzerland is equipped with small and large scale automated synthesisers for the production of oligonucleotides (DNA, antisense, siRNA) - complimenting the small and large scale stirred bed solid phase reactors. For downstream processing Lonza will use small and large scale membrane technology, Ion exchange, and ...
Piramal begins production at API facility in Michigan
Feb 20, 2023 · The facility is operated out of Michigan, US, by Piramal Pharma Solutions, a contract development and manufacturing organization (CDMO) and subsidiary of Piramal Pharma. In total, the company spent $38m (€35.5m) to expand the Riverview site, with the project beginning in May 2021. The new facility covers approximately 25,000-square-feet of ...
FDA compliance and AI drive growth for Quotient
Oct 2, 2024 · Quotient Sciences expands with mRNA Focus at CPHI 2024. During the show, Quotient Sciences CEO Thierry Van Nieuwenhove will share insights on how the company is adapting to new FDA regulations. He will also be explaining how the company is expanding its Translational Pharmaceutics platform into new therapeutic areas like mRNA, and using AI to ...